Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)

Vaccination of children born to HIV-infected mothers in accordance with the national Calendar of preventive vaccinations represents an important issue. Upon that, measles incidence rate especially among unvaccinated children has been substantially elevated. Use of live measles vaccine in both HIV-in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	N. F. Snegova, M. P. Kostinov, D. V. Pakhomov, N. I. Ilina
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2019
Materias:	hiv-infection children born to hiv-infected mothers vaccination measles vaccine Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/c0d9a6b72c90482b88e158bea945088c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c0d9a6b72c90482b88e158bea945088c
record_format	dspace
spelling	oai:doaj.org-article:c0d9a6b72c90482b88e158bea945088c2021-11-22T07:09:53ZMeasles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)2220-76192313-739810.15789/2220-7619-2019-2-325-336https://doaj.org/article/c0d9a6b72c90482b88e158bea945088c2019-07-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/691https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398Vaccination of children born to HIV-infected mothers in accordance with the national Calendar of preventive vaccinations represents an important issue. Upon that, measles incidence rate especially among unvaccinated children has been substantially elevated. Use of live measles vaccine in both HIV-infected children and mothers has some features primarily due to HIV-associated immunocompromised state that was poorly investigated. Here we monitored 212 children aged 12–36 months born to HIV-infected women, 184 HIV-negative children born to HIVinfected women who were included into the group with the diagnosis “Perinatal HIV contact” (R75) after verification. In addition, 28 children were included into the group” HIV infection “(B23), whereas 42 children — into the control group. Live measles vaccine was administered subcutaneously at a dose of 0.5 ml. All children were followed up for 36 weeks. HIV status, measles antibodies level by measured by ELISA and RPG methods, as well as total immunoglobulin A, M, G classes and CD3+, CD4+, CD8+, CD19+ lymphocyte counts were examined. No post-vaccination complications or severe vaccine-induced reactions were reported in HIV-infected patients group. A satisfactory course of the vaccine process in all children born to HIV-infected mothers was observed that did not significantly differ from that one in control group. Children with perinatal HIV contact are able to respond adequately to vaccination with live measles vaccine. The number of children with conditionally protective antibody levels, still remaining seronegative among children with perinatal HIV contact (R75) was comparable to that one in healthy control group. At the same time, children with perinatal HIV contact were shown to display protective antibody level after administering live measles vaccine only in 36.4% of cases, whereas the remainder (63.6%) demonstrated a conditionally protective antibody level or lack it (compared to 76% of children with perinatal HIV contact). Children with perinatal HIV infection who did not respond to the first administered live measles vaccine produced low amount of antibodies after re-vaccination. Seroconversion was observed in up to 68% of cases, whereas protective antibody level was found in up to 33.6% of child ren. On the contrary, children from the perinatal HIV contact group were shown to have protective antibody level in 69.6% of cases upon seroconversion rate reaching 91.3% that did not differ them from those in control group. In the post-vaccination period, suppressive modality of immune reaction tended to increase indirectly evidenced by increased percentage of CD8+ T cell subset.N. F. SnegovaM. P. KostinovD. V. PakhomovN. I. IlinaSankt-Peterburg : NIIÈM imeni Pasteraarticlehiv-infectionchildren born to hiv-infected mothersvaccinationmeaslesvaccineInfectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 9, Iss 2, Pp 325-336 (2019)
institution	DOAJ
collection	DOAJ
language	RU
topic	hiv-infection children born to hiv-infected mothers vaccination measles vaccine Infectious and parasitic diseases RC109-216
spellingShingle	hiv-infection children born to hiv-infected mothers vaccination measles vaccine Infectious and parasitic diseases RC109-216 N. F. Snegova M. P. Kostinov D. V. Pakhomov N. I. Ilina Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)
description	Vaccination of children born to HIV-infected mothers in accordance with the national Calendar of preventive vaccinations represents an important issue. Upon that, measles incidence rate especially among unvaccinated children has been substantially elevated. Use of live measles vaccine in both HIV-infected children and mothers has some features primarily due to HIV-associated immunocompromised state that was poorly investigated. Here we monitored 212 children aged 12–36 months born to HIV-infected women, 184 HIV-negative children born to HIVinfected women who were included into the group with the diagnosis “Perinatal HIV contact” (R75) after verification. In addition, 28 children were included into the group” HIV infection “(B23), whereas 42 children — into the control group. Live measles vaccine was administered subcutaneously at a dose of 0.5 ml. All children were followed up for 36 weeks. HIV status, measles antibodies level by measured by ELISA and RPG methods, as well as total immunoglobulin A, M, G classes and CD3+, CD4+, CD8+, CD19+ lymphocyte counts were examined. No post-vaccination complications or severe vaccine-induced reactions were reported in HIV-infected patients group. A satisfactory course of the vaccine process in all children born to HIV-infected mothers was observed that did not significantly differ from that one in control group. Children with perinatal HIV contact are able to respond adequately to vaccination with live measles vaccine. The number of children with conditionally protective antibody levels, still remaining seronegative among children with perinatal HIV contact (R75) was comparable to that one in healthy control group. At the same time, children with perinatal HIV contact were shown to display protective antibody level after administering live measles vaccine only in 36.4% of cases, whereas the remainder (63.6%) demonstrated a conditionally protective antibody level or lack it (compared to 76% of children with perinatal HIV contact). Children with perinatal HIV infection who did not respond to the first administered live measles vaccine produced low amount of antibodies after re-vaccination. Seroconversion was observed in up to 68% of cases, whereas protective antibody level was found in up to 33.6% of child ren. On the contrary, children from the perinatal HIV contact group were shown to have protective antibody level in 69.6% of cases upon seroconversion rate reaching 91.3% that did not differ them from those in control group. In the post-vaccination period, suppressive modality of immune reaction tended to increase indirectly evidenced by increased percentage of CD8+ T cell subset.
format	article
author	N. F. Snegova M. P. Kostinov D. V. Pakhomov N. I. Ilina
author_facet	N. F. Snegova M. P. Kostinov D. V. Pakhomov N. I. Ilina
author_sort	N. F. Snegova
title	Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)
title_short	Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)
title_full	Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)
title_fullStr	Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)
title_full_unstemmed	Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)
title_sort	measles vaccination of children born to hiv-infected mothers (clinical and immunological aspects)
publisher	Sankt-Peterburg : NIIÈM imeni Pastera
publishDate	2019
url	https://doaj.org/article/c0d9a6b72c90482b88e158bea945088c
work_keys_str_mv	AT nfsnegova measlesvaccinationofchildrenborntohivinfectedmothersclinicalandimmunologicalaspects AT mpkostinov measlesvaccinationofchildrenborntohivinfectedmothersclinicalandimmunologicalaspects AT dvpakhomov measlesvaccinationofchildrenborntohivinfectedmothersclinicalandimmunologicalaspects AT niilina measlesvaccinationofchildrenborntohivinfectedmothersclinicalandimmunologicalaspects
_version_	1718417942190751744

Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)

Ejemplares similares